Tickets for From discovery to deal: Creating, protecting and licensing intellectual property

LithuaniaBIO and Sorainen law firm proudly present the EU Biotech Playbook – a dedicated lecture series for biotech companies navigating legal and regulatory challenges. The second seminar, taking place on 28 April 2026, 10:00–11:30 via Microsoft Teams, delivered by Sorainen IP lawyers Marijus Dingilevskis and Olivia Kranich, will guide participants through the intellectual property challenges biotech companies face across the full innovation lifecycle.

Building a successful biotech company requires more than great science – it demands a clear strategy for creating, protecting, and monetising your intellectual property. In this seminar, we will explore how to structure IP ownership in collaborations and partnerships, when to choose patents over trade secrets, and how to design licensing strategies that capture the value of your work.

Key topics include:

✅ Structuring IP ownership in research collaborations and university partnerships

✅ Patent strategy vs. trade-secret strategy in biotech: how to choose 

✅ Licensing models (materials, datasets, algorithms, assays) and common negotiation pitfalls

✅ Tech-transfer readiness: documentation, data rooms, and freedom-to-operate basics

Why attend?

Participants will leave with a clearer understanding of how to protect and leverage their intellectual property assets, avoid common pitfalls in collaborations and licensing, and be better prepared to capture the full value of their innovations.

This seminar is particularly relevant for: 

✅ Biotech & life science founders and executives 

✅ In-house legal and IP teams 

✅ R&D, business development, and strategy leaders 

✅ Investors and advisors in life sciences